Publications
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia2018 | First Faculty of Medicine, Central Library of Charles University
- MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia2011 | First Faculty of Medicine
- Will we progress in CLL therapy?2011 | First Faculty of Medicine
- MicroRNA Mir-155 and Myb Proto-Oncogene Family Members Cooperate in Pathogenesis of Chronic Lymphocytic LeukemiaPublication without faculty affiliation
- Blast phase of chronic myeloid leukaemia2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Symposium and workshop - actual challenges and implementation of new technologies in the treatment of chronic myeloid leukaemia2023 | First Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells2021 | First Faculty of Medicine
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.2018 | First Faculty of Medicine, Central Library of Charles University
- Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment2017 | First Faculty of Medicine, Faculty of Science, Faculty of Medicine in Hradec Králové
Loading network view...